Properties (59)
Predicate | Object |
---|---|
gptkbp:instanceOf |
biotechnology company
|
gptkbp:acquisition |
acquired_by_Iveric_Bio
|
gptkbp:advertising |
targeted therapies
focus on unmet medical needs |
gptkbp:benefits |
aims to impact healthcare positively
|
gptkbp:businessModel |
biopharmaceutical development
strategic growth initiatives |
gptkbp:CEO |
gptkb:David_R._Guyer
|
gptkbp:challenges |
competition in biotechnology
|
gptkbp:clinicalTrials |
improve patient outcomes
multiple drug candidates Phase 3 trials ongoing studies collaborative research efforts retinal diseases Phase 2 trials advancements in treatment options focus on drug development treatment of retinal diseases novel drug discovery efforts |
gptkbp:collaborations |
academic institutions
partnerships with research institutions collaborations with clinical sites |
gptkbp:community_involvement |
support for health initiatives
|
gptkbp:competitors |
conducting market research
|
gptkbp:employees |
approximately 50
|
gptkbp:financials |
public and private funding
focused on innovation |
gptkbp:focus |
ophthalmology
|
gptkbp:founded |
2007
|
gptkbp:founder |
gptkb:David_R._Guyer
|
gptkbp:funding |
grants and investments
|
gptkbp:future_plans |
expand product offerings
|
gptkbp:headquarters |
gptkb:New_York_City
|
https://www.w3.org/2000/01/rdf-schema#label |
Ophthotech Corporation
|
gptkbp:investmentFocus |
2015
venture capital firms significant venture capital investments engagement with investors |
gptkbp:leadership |
experienced management team
|
gptkbp:market |
global pharmaceutical market
growing presence in ophthalmology |
gptkbp:partnerships |
various pharmaceutical companies
strategic alliances |
gptkbp:productLine |
diverse product pipeline
|
gptkbp:products |
gptkb:Fovista
innovative therapies |
gptkbp:publications |
research articles
|
gptkbp:regulatoryCompliance |
various regulatory bodies
FDA_submissions |
gptkbp:research |
ongoing research initiatives
dedicated to scientific research |
gptkbp:research_areas |
eye diseases
anti-VEGF therapy age-related macular degeneration multiple candidates in development innovative therapeutic approaches |
gptkbp:stockExchange |
OPHT
|
gptkbp:website |
www.ophthotech.com
|